A study, performed by the Medical University of Vienna, examined diagnostic accuracy of SARS-CoV-2 rapid antigen tests compared to RT-PCR as the gold standard based on different swab sites by using Scarletred®Vision.

The business magazine Gewinn discusses how Scarletred®Vision is an excellent addition to the safety and monitoring of injection site reactions (ISRs) in vaccine development.

The national platform IÖB (public procurement promoting innovation) announced Austria’s top innovations. This year, the IÖB awarded SCARLETRED with Scarletred®Vision as a digital healthcare management solution.

With patient safety in mind, SCARLETRED®Vision can be used as a digital aid to measure and document treatment safety and efficacy of newly developed JAK inhibitors either on site and/or home based clinical trials.

The traditional assessment of skin texture based on multiple health professionals can lead to inconsistent results making standardized digital dermatological monitoring, as provided by SCARLETRED, an essential tool.

Being a chronic inflammatory skin disorder, patients with rosacea need standardized tools, as provided by SCARLETRED, to improve the condition’s analysis and treatment and overcome psychosocial stigmatization.

Vitiligo is a long-term pigmentation disorder affecting 0.5 - 1% of individual. SCARLETRED is revolutionizing dermatology by allowing the standardization of the assessment and monitoring of vitiligo.

Chronic wound is a medical condition, affecting up to 4% of all people worldwide. The wound care market is one of the biggest in the healthcare system globally, standing now at approx. USD 10.4 billion.

Non-healing wounds pose a significant challenge in clinical medicine and present severe difficulties to millions of patients worldwide. The management of chronic wounds remains a challenging task in terms of their assessment.